kw.\*:("Merciton")
Results 1 to 1 of 1
Selection :
Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinylestradiolLAMMERS, P; OF TEN BERG, M.Acta obstetricia et gynecologica Scandinavica. 1991, Vol 70, Num 6, pp 497-500, issn 0001-6349Article
